NCT06673914View on ClinicalTrials.gov

EFFECTS OF OLEUROPEIN ON BLOOD PARAMETERS AND INFLAMMATORY MARKERS IN ADULTS WITH METABOLIC SYNDROME

NAActive, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 30, 2024

Study Completion Date

January 15, 2025

Conditions
Metabolic SyndromeInsulin ResistanceObesity, AbdominalObesity
Interventions
BEHAVIORAL

Control Group: Diet Group

"Patient in Diet Group and Oleuropein and Diet Group will be given a personalized diet and be followed up by a dietician."

DIETARY_SUPPLEMENT

Oleuropein and Diet Group

"Dietary Supplement: Oleuropein (Olive Leaf Extract) Patients in Oleuropein and Diet Group will receive 200 mg/day oleuropein supplement and personalized diet followed up by a dietician."

Trial Locations (1)

34413

Atlas University, Istanbul

All Listed Sponsors
lead

Atlas University

OTHER

NCT06673914 - EFFECTS OF OLEUROPEIN ON BLOOD PARAMETERS AND INFLAMMATORY MARKERS IN ADULTS WITH METABOLIC SYNDROME | Biotech Hunter | Biotech Hunter